61314-266 : Zarxio 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution
| NDC: | 61314-266 |
| Labeler: | Sandoz Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Zarxio |
| Dosage Form: | Intravenous; Subcutaneous Injection, Solution |
| Application #: | BLA125553 |
| Rev. Date: |
Active Ingredients:
- Filgrastim
Dosage Strength:
- 480 ug/1.6mL
Pharmaceutical Classes:
- Granulocyte Colony-Stimulating Factor [CS]
- Granulocyte-Macrophage Colony-Stimulating Factor [CS]
- Increased Myeloid Cell Production [PE]
- Leukocyte Growth Factor [EPC]
Related Products:
Based on records with the same trade name.- 61314-246 Zarxio 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
- 61314-318 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
- 61314-326 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
- 61314-304 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
- 61314-312 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 61314-246Next: 61314-271 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.